🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 21 of 30

  1. US 7906523

    Dipeptidyl peptidase inhibitors

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7897607

    Cyclic compounds

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7892755

    Screening method

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7879564

    Use of the receptor GPR86

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7875292

    Orally disintegrable tablets

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7872124

    Dipeptidyl peptidase inhibitors

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7851473

    Amide compound

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7842706

    Pharmaceutical composition

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7842701

    Pyrazoloquinolone derivative and use thereof

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7833722

    Ligands for G protein-coupled receptor protein and use thereof

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7833972

    Proteins and use thereof

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7834051

    Cyclic amine compounds

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7825242

    Dipeptidyl peptidase inhibitors

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7825127

    Method for treating cancer

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7820673

    Urea derivative, process for producing the same, and use

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7820837

    Condensed ring compound

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7812025

    Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7812044

    Anticancer agents

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7807689

    Dipeptidyl peptidase inhibitors

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7803940

    Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7803822

    Triazole derivative and use thereof

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7799533

    Polypeptides, their production and use

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7795428

    Dipeptidyl peptidase inhibitors

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7795267

    Bicyclic piperazine compound having TGR23 antagonistic activity

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7790736

    Dipeptidyl peptidase inhibitors

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7790755

    Controlled release preparation

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7790734

    Dipeptidyl peptidase inhibitors

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7786165

    Aminophenylpropanoic acid derivative

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7786083

    Metastin derivatives and use thereof

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7781584

    Dipeptidyl peptidase inhibitors

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7781175

    Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid

    Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7777047

    Indole compound

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7767665

    1,3-benzothiazinone derivatives and use thereof

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7763716

    Antibody against NPW

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7759339

    Hydroxysteroid dehydrogenase inhibitors

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7754220

    Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7754856

    Human sodium-dependent bile acid transporter proteins

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7750037

    Antidepressant

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7745623

    Cyclic amide derivative, and its production and use

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7741494

    Histone deacetylase inhibitors

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7737282

    Benzimidazole compound crystal

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7732446

    Dipeptidyl peptidase inhibitors

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7732626

    Fused cyclic compounds

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7732475

    Histone deacetylase inhibitors

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7723496

    Preventives/remedies for cancer

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7723344

    Dipeptidyl peptidase inhibitors

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7718798

    Indole compound

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.